Head to head

ResurFX vs Fraxel FTX (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: No new-price range is on file for either ResurFX or Fraxel FTX. Request current quotes to compare purchase costs.
Practice fit: Both are listed under non-ablative fractional. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Non-Ablative Fractional

View full device profile →

Device B

Non-Ablative Fractional

View full device profile →

Price comparison

Price comparison: Lumenis ResurFX (M22/Stellar module) vs Solta Medical Fraxel FTX
Attribute	Lumenis ResurFX (M22/Stellar module)	Solta Medical Fraxel FTX
New price range	Not published	Not published
Used asking range	Not published	Not published
Payback calculator	View cost details	View cost details
Next step

New price range

Lumenis ResurFX (M22/Stellar module): Not published
Solta Medical Fraxel FTX: Not published

Used asking range

Lumenis ResurFX (M22/Stellar module): Not published
Solta Medical Fraxel FTX: Not published

Payback calculator

Lumenis ResurFX (M22/Stellar module): View cost details
Solta Medical Fraxel FTX: View cost details

Next step

Lumenis ResurFX (M22/Stellar module)

Solta Medical Fraxel FTX

Consumable economics

Consumable economics: Lumenis ResurFX (M22/Stellar module) vs Solta Medical Fraxel FTX
Attribute	Lumenis ResurFX (M22/Stellar module)	Solta Medical Fraxel FTX
Consumable cost / lock-in	—	Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Service cost	Not published	Not published

Consumable cost / lock-in

Lumenis ResurFX (M22/Stellar module): —
Solta Medical Fraxel FTX: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

Service cost

Lumenis ResurFX (M22/Stellar module): Not published
Solta Medical Fraxel FTX: Not published

FDA clearance

FDA clearance: Lumenis ResurFX (M22/Stellar module) vs Solta Medical Fraxel FTX
Attribute	Lumenis ResurFX (M22/Stellar module)	Solta Medical Fraxel FTX
FDA status & indication	FDA ClearedK170060 Read FDA indication wording “The subject Lumenis M22 System has connection capability with the following available treatment handpieces, for multiapplication treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows: xx The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200nm (with 10 different filters) is indicated for: • Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles) and tattoos • Cutaneous lesions, including warts, scars and striae • Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations • Removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • Mild to moderate inflammatory Acne (Acne vulgaris) x The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: • The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm. diameter) of the leg • The removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • The non-ablative treatment of facial wrinkles x ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: • Use in dermatological procedures requiring fractional skin resurfacing and coagulation of soft tissue x The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064nm is indicated for: • Removal of dark tattoos • Treatment of pigmented lesions *Note Permanent hair reduction is defined as long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The ResurFX System with wavelength of 1565 nm, is indicated for use in dermatological procedures requiring fractional skin resurfacing and coagulation of soft tissue.”	FDA ClearedK242142 Read FDA indication wording “1550 nm: The Fraxel 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. It is also indicated for treatment of dyschromia and cutaneous lesions, such as, but not limited to lentigos (age spots), solar lentigos (sunspots), actinic keratosis, and melasma, and for treatment of periorbital wrinkles, acne scars and surgical scars. 1927 nm: The Fraxel 1927 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots) and ephelides (freckles).”

FDA status & indication

Lumenis ResurFX (M22/Stellar module): FDA ClearedK170060
Read FDA indication wording
“The subject Lumenis M22 System has connection capability with the following available treatment handpieces, for multiapplication treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows: xx The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200nm (with 10 different filters) is indicated for: • Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles) and tattoos • Cutaneous lesions, including warts, scars and striae • Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations • Removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • Mild to moderate inflammatory Acne (Acne vulgaris) x The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: • The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm. diameter) of the leg • The removal of unwanted hair from all skin types, and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles • The non-ablative treatment of facial wrinkles x ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: • Use in dermatological procedures requiring fractional skin resurfacing and coagulation of soft tissue x The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064nm is indicated for: • Removal of dark tattoos • Treatment of pigmented lesions *Note Permanent hair reduction is defined as long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The ResurFX System with wavelength of 1565 nm, is indicated for use in dermatological procedures requiring fractional skin resurfacing and coagulation of soft tissue.”
Solta Medical Fraxel FTX: FDA ClearedK242142
Read FDA indication wording
“1550 nm: The Fraxel 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. It is also indicated for treatment of dyschromia and cutaneous lesions, such as, but not limited to lentigos (age spots), solar lentigos (sunspots), actinic keratosis, and melasma, and for treatment of periorbital wrinkles, acne scars and surgical scars. 1927 nm: The Fraxel 1927 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots) and ephelides (freckles).”

Which chains run each

Which chains run each: Lumenis ResurFX (M22/Stellar module) vs Solta Medical Fraxel FTX
Attribute	Lumenis ResurFX (M22/Stellar module)	Solta Medical Fraxel FTX
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Lumenis ResurFX (M22/Stellar module): 0 recorded pairings
Solta Medical Fraxel FTX: 0 recorded pairings

Chains using it

Lumenis ResurFX (M22/Stellar module): —
Solta Medical Fraxel FTX: —

Approved reviews

Lumenis ResurFX (M22/Stellar module): 0
Solta Medical Fraxel FTX: 0

Specs and platform

Specs and platform: Lumenis ResurFX (M22/Stellar module) vs Solta Medical Fraxel FTX
Attribute	Lumenis ResurFX (M22/Stellar module)	Solta Medical Fraxel FTX
Manufacturer	Lumenis	Solta Medical
Built by (OEM)	Lumenis Be Ltd.	Solta Medical Inc.
Category	Non-Ablative Fractional	Non-Ablative Fractional
Technology	1565nm erbium-glass fractional scanner (Erbium)	Fractional resurfacing laser
Launch year	2014	—
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Lumenis ResurFX (M22/Stellar module): Lumenis
Solta Medical Fraxel FTX: Solta Medical

Built by (OEM)

Lumenis ResurFX (M22/Stellar module): Lumenis Be Ltd.
Solta Medical Fraxel FTX: Solta Medical Inc.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Solta Fraxel Dual (re:store Dual)

Non-Ablative Fractional

New: $90k–$120k

Lutronic LaseMD Ultra

Non-Ablative Fractional

New: $60k–$90k

Palomar/Cynosure Icon

Non-Ablative Fractional

New: $70k–$100k

Candela Frax Pro (Nordlys)

Non-Ablative Fractional

New: —

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.